Michael Cooper, MD
Cardiovascular Disease · Greensboro, NCNPI 1992929137
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,635 of the $11,797 with a category attached, or 81.7%. 36 manufacturers reported payments, led by Abbott at 39.5% of the total. Reporting peaked in 2019 at $3,481 and has fallen 78.5% since, to $748 in 2025.
Across 336 payments — averaging $35.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$5K
- Edwards Lifesciences$1K
- Boston Scientific$1K
- Amgen$841
- Abiomed$578
- Medtronic$494
- plus $3K from 30 others
Across 199 payments — averaging $3018.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$329K
- Novartis$153K
- Abbott$60K
- Biotronik Inc.$31K
- Daiichi Sankyo Inc.$29K
What the payments were for
- Travel & lodging$2,14918%
- Food & beverage$9,63582%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 58 | $4,658 |
| Edwards Lifesciences | 25 | $1,056 |
| Boston Scientific | 26 | $1,029 |
| Amgen | 54 | $841 |
| Abiomed | 20 | $578 |
| Medtronic(2 entities) | 10 | $494 |
| Novartis | 34 | $465 |
| Shockwave Medical, Inc | 5 | $454 |
| Penumbra, Inc. | 2 | $300 |
| Johnson & Johnson | 18 | $236 |
| Pfizer | 12 | $205 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $201 |
| Cardiovascular Systems Inc. | 8 | $171 |
| Sanofi-aventis U.S. LLC | 7 | $127 |
| Boehringer Ingelheim | 8 | $126 |
| AstraZeneca | 9 | $114 |
| Terumo Medical Corporation | 1 | $111 |
| Chiesi USA, Inc. | 3 | $108 |
| Biosense Webster, Inc. | 2 | $88 |
| Irhythm Technologies, Inc. | 3 | $48 |
| E.r. Squibb & Sons, L.L.C. | 3 | $43 |
| Merck | 3 | $40 |
| Acist Medical Systems, Inc. | 1 | $36 |
| Bayer | 2 | $31 |
| GSK | 1 | $30 |
| Esperion Therapeutics, Inc. | 2 | $30 |
| Scpharmaceuticals Inc. | 1 | $24 |
| Portola Pharmaceuticals, LLC | 1 | $23 |
| Cardiva Medical, Inc. | 1 | $20 |
| Heartflow, Inc. | 1 | $18 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $17 |
| Lexicon Pharmaceuticals, Inc. | 1 | $16 |
| Novo Nordisk | 1 | $15 |
| Teleflex LLC | 1 | $14 |
| Biotronik Inc. | 1 | $14 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Mitra Clip system$1,988
- MitraClip$1,155
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$306
- COREVALVE EVOLUT R$284
- SAPIEN 3 Ultra RESILIA$269
- WATCHMAN Access System$265
- GENERAL - STRUCTURAL HEART$171
- Indigo System$160
- TRICLIP$150
- OPTIS$140
- Indigo$140
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$125
- Impella$116
- PASCAL$115
- GlideWire$111
- Heartrail$111
- METACROSS OTW$111
- Vascular Lithotripsy$104
How this compares
$11,797 in reported general payments places this provider in the 80th percentile of 727 cardiovascular disease providers in North Carolina.
See all cardiovascular disease providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 513 | $455,149 |
| Repatha SureclickEvolocumab | 197 | $173,781 |
| EntrestoSacubitril/Valsartan | 95 | $100,911 |
| JardianceEmpagliflozin | 52 | $50,212 |
| Praluent PenAlirocumab | 53 | $41,431 |
| XareltoRivaroxaban | 21 | $23,212 |
| VascepaIcosapent Ethyl | 26 | $13,283 |
| Rosuvastatin Calcium | 428 | $7,447 |
| Ezetimibe | 272 | $7,338 |
| Metoprolol Succinate | 375 | $5,666 |
| Atorvastatin Calcium | 382 | $5,395 |
| ClopidogrelClopidogrel Bisulfate | 365 | $4,664 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 218 | $3,105 |
| Carvedilol | 308 | $3,053 |
| Amlodipine Besylate | 366 | $2,396 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $205 | $455,149513 claims |
| NovartisEntresto | $465 | $100,91195 claims |
| Boehringer IngelheimJardiance | $126 | $50,21252 claims |
| Johnson & JohnsonXarelto | $236 | $23,21221 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 727 cardiovascular disease providers in North Carolina.
Other cardiovascular disease in Greensboro
- Tiffany RandolphGreensboro$133K
- Cameron LambertGreensboro$99K
- Wesley O'NealGreensboro$85K
- Kenneth HiltyGreensboro$51K
- Katarina NelsonGreensboro$46K
- R WilliamsDurham$2.1M
- Marat FudimDurham$902K
- Jonathan PicciniDurham$767K
- Michael RinaldiCharlotte$722K
- Markus SchererCharlotte$526K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.